BRKR - Mergers and acquisitions

TOFWERK is a profitable innovator in compact, ultra-fast time-of-flight (TOF) mass spectrometry for real-time air and semiconductor cleanroom monitoring, food, flavors & fragrances markets, and FIB-TOF accessories for electron microscopes The ultra-sensitive Vocus™ TOF-MS is customizable for real-time air and cleanroom monitoring applications Microwave-induced plasma (MIP)-TOF systems with atto-to-femtogram detection limits for real-time quantification of trace elements and metals Proprietary flow tube-based VUV CI sources for positive and negative trace organics, inorganics and PFAS contaminants Focused Ion Beam (FIB)-TOF accessories for scanning electron microscopes Bruker

Acquisition further expands Bruker's multiomics strategy with biocrates metabolomics kits and assays, and related software and research services Bruker Corporation (NASDAQ:BRKR) today announced the acquisition of biocrates life sciences ag, located in Innsbruck, Austria. Financial terms were not disclosed. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250603323690/en/biocrates kits and pipettes biocrates is a global leader in mass spectrometry (MS)-based quantitative metabolite and lipid analysis kits, assays, software and services that make standardized metabolomics accessible to laboratories worldwide. The biocrates kits co

Combining Dynamic Biosensors' Innovative Technologies with Bruker's High-Performance SPR Portfolio to Establish a Leading Biosensors Business Bruker Corporation (NASDAQ:BRKR) today announced the acquisition of Dynamic Biosensors GmbH, a pioneering company known for its breakthroughs in biosensor development, which is based in Munich, Germany. This acquisition strengthens Bruker's biophysical portfolio for the analysis of molecular interactions and kinetics, offering deeper insights into both inter-molecular and molecule-single cell interactions in drug discovery or basic research. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202

Nanophoton Strengthens Bruker's Portfolio of Molecular Microscopy Research Solutions Bruker Corporation (NASDAQ:BRKR) today announced the acquisition of Nanophoton Corporation, a pioneer focused on advanced research Raman microscopy systems. Headquartered in Osaka, Nanophoton offers a broad portfolio of advanced Raman microscopes, serving academic and industrial research customers, primarily in Japan. This acquisition fills a gap in Bruker's molecular microscopy portfolio, and Bruker is looking forward to offering fast, flexible and sensitive Nanophoton Raman microscopy systems worldwide for research and development in the life sciences, biopharma, advanced materials, semiconductors and p

Acquisition Complements Bruker's Preclinical Imaging Portfolio with In-Vivo Optical Imaging Bruker Corporation (NASDAQ:BRKR) today announced that it has acquired Spectral Instruments Imaging LLC, a leader in preclinical in-vivo optical imaging systems. This acquisition fills a gap in the technology and product portfolio of the Bruker BioSpin Preclinical Imaging (PCI) division, broadening its range of preclinical solutions for disease research. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240206814523/en/Fast and highest sensitivity SII Lago X in vivo imaging with capacity for 10 animals simultaneously (Photo: Business Wire)

Bruker Corporation (NASDAQ:BRKR) today announced that it has completed the acquisition of PhenomeX, a leading provider of single-cell biology research tools, for $108 million in cash. Bruker announced the agreement to acquire PhenomeX on August 17, 2023. PhenomeX is a functional cell biology company that provides single-cell biology research tools to deliver deep insights into cellular function and new perspectives on phenomes and genotype-to-phenotype linkages. PhenomeX key platforms include the Beacon® line of Optofluidic systems, which enables researchers to accelerate biologics product development by functional characterization of tens of thousands of single cells in parallel, while m

Adding Big-Data Management and High-Content Screening Solutions for Bioimaging Applications Bruker Corporation (NASDAQ:BRKR) today announced the acquisition of ACQUIFER Imaging GmbH, a pioneer in big-data management solutions for bioimaging and high-content microscopy. This acquisition adds high-performance on-premise processing, secure storage and networking technology that complements Bruker's advanced fluorescence microscopy imaging products, such as light-sheet and super-resolution microscopy products, which generate high information content. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230105006017/en/Acquifer's HIVE data

Head-Mounted Miniscopes Expand Neural Functional Imaging Capabilities Bruker Corporation (NASDAQ:BRKR) today announced the acquisition of Inscopix, Inc., a neuroscience pioneer and market leader of miniaturized microscopes, known as miniscopes, for freely moving animal brain imaging. Since its founding in 2011, Inscopix's flagship miniscope systems have been deployed in over 600 research institutions and biopharma companies worldwide, empowering breakthroughs in fundamental neuroscience research and advancing the understanding of mechanisms in neurological disorders. This acquisition enhances Bruker's strong reputation as a technology leader for in-vivo brain functional imaging with Ultima

IonSense Inc., the innovator of ambient DART™ (Direct Analysis in Real Time) ionization technology, announces that it has been acquired by Bruker Corporation (NASDAQ:BRKR). The deal provides IonSense with the financial investments to ramp up development of the DART ionization source technology and increase efforts in developing applications in the applied markets, including food analysis and forensics. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220406005746/en/Bruker acquires IonSense (Graphic: Business Wire) "This merger will help us to accelerate development of DART MS and properly resource robust applications development p

Bruker Corporation (NASDAQ:BRKR) today announced the acquisition of Optimal Industrial Automation and Technologies, a leader in pharma and biopharma process analytical technology (PAT), pharma manufacturing automation and Quality Assurance (QA) software and systems integration, based in the United Kingdom. The Optimal biopharma tools acquisition strengthens Bruker as a key software and solutions provider for small molecule, biologics and new drug modalities pharma companies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220405005227/en/The award-winning Optimal PAT knowledge management software synTQ® can help to optimize biopha

Acquires PepSep NanoLC Columns and Components Company for ease-of-use and robustness Enters into OEM agreement with IonOpticks for high-performance nanoLC Aurora columns Complementary PepSep and IonOpticks nanocolumns enhance performance and robustness of timsTOF 4D-Proteomics™ solutions PepSep packed nanocolumns for ease of use and robustness with Bruker CSI emitter IonOpticks Aurora columns with integrated emitter tips for optimized separation power   Bruker Corporation (NASDAQ:BRKR) today announced the acquisition of PepSep, a Danish company specializing in nanoflow liquid chromatography (nanoLC) columns, specialty emitters and components to optimize nanoflow proteomics workf

Prolab precision pumps, autosamplers and nano-flow to cap-LC UHPLC systems to further enhance performance and robustness of timsTOF 4D proteomics and metabolomics solutions Unique Zirconium™ nano-LC to cap-LC pump technology for 4 nL/min to 10 μL/min flow rates with split-less UHPLC operation for optimized proteomics results Innovative, proprietary Zirconium Cube™ autosampler with mobile injection unit technology for precise, ultra-low volume injections in high sensitivity single-cell proteomics and immunopeptidomics ZircoFIT™ UHPLC fittings for robust, easy-to-use nano- to cap-LC fused silica connections to enhance chromatographic peak shapes New Zirconium™ Ultra UHPLC System for c

Expands Nuclear Molecular Imaging Portfolio with Modular Benchtop CUBES™ PET, SPECT and CT Preclinical Imaging Systems Bruker Corporation (NASDAQ:BRKR) today announced the acquisition of MOLECUBES NV, a dynamic innovator in benchtop preclinical nuclear molecular imaging (NMI) systems. This acquisition strengthens Bruker's position as a leading NMI solutions provider in preclinical and translational imaging research. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211119005258/en/Modular benchtop CUBES™ NMI systems of MOLECUBES (Photo: Business Wire) The combination of Bruker's preclinical imaging products and global footprint wit